Persistent long-term changes in lymphocyte subsets induced by polyclonal antibodies

Transplantation

Volumn 64, Issue 10, 1997, Pages 1432-1437

  Müller, Thomas F ^a   Grebe, Scott O ^a   Neumann, M Christine ^a   Heymanns, Jochen ^a   Radsak, Klaus ^a   Sprenger, Hans ^a   Lange, Harald ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD57 ANTIGEN; CD8 ANTIGEN; CYCLOSPORIN A; HLA DR ANTIGEN; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; NEOPTERIN; OKT 3; POLYCLONAL ANTIBODY; PREDNISOLONE; SERUM AMYLOID A; STEROID; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CYTOMEGALOVIRUS INFECTION; DOSE RESPONSE; EPSTEIN BARR VIRUS; FEMALE; HELPER CELL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY GRAFT REJECTION; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

EID: 0030730836     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199711270-00010     Document Type: Article

References (40)

1. Kaden J, May G, Strobelt V, Groth J, Müller P. Intraoperative T-cell depletion prior to completion of anastomoses by high-dose single ATG-bolus as a new approach to improve long-term results after kidney transplantation. Transplant Proc 1997; 29: 344.
2. Bock HA, Gallati H, Zürcher RM, et al. A randomized prospective trial of prophylactic immunosuppression with ATG-Fresenius versus OKT3 after renal transplantation. Transplantation 1995; 59: 830.
3. Abouna GM, Al-Abdullah IH, Kelly-Sullivan D, et al. Randomized clinical trial of antithymocyte globulin induction in renal transplantation comparing a fixed daily dose with dose adjustment according to T cell monitoring. Transplantation 1995; 59: 1564.
4. Bach JF, Chatenoud L. Immunology of monoclonal antibodies in solid organ transplantation: yesterday, today and tomorrow. Transplant Sci 1992; 2: 4.
5. Moreland LW, Pratt PW, Bucy RP, Jackson BS, Feldman JW, Koopman WJ. Treatment of refractory rheumatoid arthritis with chimeric anti-CD4 monoclonal antibody. Arthritis Rheum 1994; 37: 834.
6. Goronzy JJ, Weyand CM. Long-term immunomodulatory effects of T lymphocyte depletion in patients with systemic sclerosis. Arthritis Rheum 1990; 33: 1.
7. Chatenoud L, Jonker M, Villemain F, Goldstein G, Bach JF. The human immune response to the OKT3 monoclonal antibody is oligoclonal. Science 1986; 232: 1406.
8. Hibberd PL, Tolkoff-Rubin NE, Cosimi AB, et al. Symptomatic cytomegalovirus disease in the cytomegalovirus antibody seropositive renal transplant recipient treated with OKT3. Transplantation 1992; 53: 68.
9. Hibberd PL, Tolkoff-Rubin NE, Conti D, et al. Preemptive ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus antibody-positive renal transplant recipients. Ann Intern Med 1995; 123: 18.
10. Müller TF, Sprenger H, Keuchel M, et al. Diagnosis of viral infections under therapy with OKT3 and antithymocyte globulin. Transplant Proc 1992; 24: 2636.
11. Swinnen LJ, Costanzo-Nordin MR, Fisher SG, et al. Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac transplant recipients. N Engl J Med 1990; 323: 1723.
12. Müller TF, Schindler S, Sprenger H, et al. Prospective analysis of 10 different parameters of acute renal allograft rejection. Transplant Proc 1992; 24: 2731.
13. Malle E, De Beer FC. Human serum amyloid A (SAA) protein: a prominent acute-phase reactant for clinical practice. Eur J Clin Invest 1996; 26: 427.
14. Reibnegger G, Aichberger C, Fuchs D, et al. Posttransplant neopterin excretion in renal allograft recipients: a reliable diagnostic aid for acute rejection and predictive marker of long-term graft survival. Transplantation 1991; 52: 58.
15. Fuchs D, Weiss G, Reibnegger G, Wachter H. The role of neopterin as a monitor of cellular immune activation in transplantation, inflammatory, infectious, and malignant diseases. Crit Rev Clin Lab Sci 1992; 29: 307.
16. Hocke G, Ebel H, Bittner K, Müller T, Kaffarnik H, Steinmetz A. A rapid laser immuno-nephelometric assay for serum amyloid A (SAA) and its application to the diagnosis of kidney allograft rejection. Klin Wochenschr 1989; 67: 447.
17. Zimmermann B, Swain SL, Dutton RW. Immunosuppressive ATS. V. Analysis of the effect of anti-thymocyte serum on T lymphocyte subsets. J Immunol 1982; 129: 515.
18. Carver M, Thomas F, Deepe R, Warren R, Thomas J. Selective action of rabbit antithymocyte globulin (RATG) on OKT4 positive T cell subset in rhesus monkeys. Transplant Proc 1983; 15: 627.
19. Olausson M, Mjörnstedt L, Blohme I, Wramner L, Söderström T. Is a persistently low level of T-helper cells a marker of rejection in renal transplant patients ? Transplant Proc 1992; 24: 300.
20. Olausson M, Wramner L, Kjellson B, Mjörnstedt L, Söderström T. Alteration in T cell subset phenotypes as cell markers for rejection or long-term allograft acceptance in allograft rats treated with antithymocyte globulin. Int Arch Allergy Immunol 1993; 101: 431.
21. Sumpio BE, Dwyer JM, Flye MW. T-lymphocyte subsets in renal allograft recipients treated with cyclosporine and azathioprine. Ann Surg 1987; 205: 49.
22. Mackall CL, Fleisher TA, Brown MR, et al. Lymphocyte depletion during treatment with intensive chemotherapy for cancer. Blood 1994; 84: 2221.
23. + T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med 1995; 332: 143.
24. Thomas JM, Williams EAJ, Thomas FT, Millington GM. T cell-specific activity in rabbit anti-human thymocyte globulin. Transplantation 1978; 25: 97.
25. Bach JF. Immunosuppression. In: Hamburger J, Crosnier J, Bach JF, Kreis H, eds. Renal transplantation: theory and practice. Baltimore, London: Williams & Wilkins, 1981: 89.
26. Schooley RT, Hirsch MS, Colvin RB, et al. Association of herpes-virus infections with T-lymphocyte subset alterations, glomerulopathy, and opportunistic infections after renal transplantation. N Engl J Med 1983; 308: 307.
27. Siegel DL, Fox I, Dafoe DC, et al. Discriminating rejection from CMV infection in renal allograft recipients using flow cytometry. Clin Immunol Immunopathol 1989; 51: 157.
28. + T cells. Clin Exp Immunol 1994; 95: 465.
29. Revillard JP, Vincent C, Bonnefoy N, Morel P, Alberici G, Dupuy JM. Immunosuppression by antilymphocyte antibodies: what did we learn from ALG, ATG, and monoclonal antibodies? Transplant Clin Immunol 1989; 20: 21.
30. Kreis H, Legendre C, Chatenoud L. OKT3 in organ transplantation. Transplant Rev 1991; 5: 181.
31. Buysmann S, Bemelman FJ, Schellekens PTA, van Kooyk Y, Figdor CG, ten Berge IJM. Activation and increased expression of adhesion molecules on peripheral blood lymphocytes is a mechanism for the immediate lymphocytopenia after administration of OKT3. Blood 1996; 87: 404.
32. Freitas AA, Rocha BB. Lymphocyte lifespans: homeostasis, selection and competition. Immunol Today 1993; 14: 25.
33. McLean AR, Michie CA. In vivo estimates of division and death rates of human T lymphocytes. Proc Natl Acad Sci USA 1995; 92: 3707.
34. Hakayawa S, Saito S, Nemoto N, et al. Expression of recombinase-activating genes (RAG-1 and 2) in human decidual mononuclear cells. J Immunol 1994; 153: 4934.
35. Lynch S, Kelleher D, McManus R, O'Farrelly C. RAG-1 and RAG-2 expression in human intestinal epithelium: evidence of extrathymic T cell differentiation. Eur J Immunol 1995; 25: 1143.
36. Margolick JB, Munoz A, Donnenberg AD, et al. Failure of T-cell homeostasis preceding AIDS in HIV-1 infection: the Multicenter AIDS Cohort Study. Nat Med 1995; 1: 674.
37. Kourtis AP, Ibegbu C, Nahmias AJ, et al. Early progression of disease in HIV-infected infants with thymus dysfunction. N Engl J Med 1996; 335: 1431.
38. Halwani F, Guttmann RD, Ste-Croix H, Prud'Homme GJ. Identification of natural suppressor cells in long-term renal allograft recipients. Transplantation 1992; 54: 973.
39. + cells in human cytomegalovirus and other viral infections. Scand J Infect Dis 1995; (suppl)99: 69.
40. + human T hybridoma. Immunology 1993; 78: 205.